MDXG
MiMedx Group Inc
4.60$
-0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.8% | -41.7% | +264.9% | -10.0% | -4.3% | -71.8% | +172.1% | +103.4% | -14.9% | -92.5% | -633.0% | – | |
| – | -4.7% | -7.0% | +53.8% | +0.5% | +158.9% | +7.1% | -1.1% | +67.0% | -39.1% | -49.8% | -5.3% | – | |
| – | -5.1% | +4.2% | -5.7% | -6.9% | +23.2% | -9.2% | +11.5% | +3.5% | -49.9% | -168.9% | – | – | |
| – | – | – | – | +49.5% | -87.6% | -2,682.0% | – | – | – | – | -101.0% | – | |
| – | -32.0% | +1,338.9% | -93.2% | +1,146.5% | -95.0% | +43.3% | -42.7% | +1,714.4% | -90.4% | +51.2% | +24.0% | – | |
| – | -25.9% | +1,152.4% | -85.0% | – | -2,548.7% | -85.3% | +118.5% | +492.8% | -93.6% | +1,584.2% | -88.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -77.4% | -83.8% | -68.5% | -72.7% | +8,093.3% | -78.6% | -84.2% | -38.6% | +3,627.5% | +562.5% | – | |
| – | – | – | – | – | -7.6% | +7.8% | +0.0% | +0.0% | +0.0% | +50.0% | +0.0% | – | |
| – | -2,516.2% | +274.4% | -98.9% | – | -1,581.5% | +619.5% | -62.0% | -21.7% | -32.0% | +343.4% | +413.9% | – | |
| – | -93.3% | -4,108.7% | – | -3.8% | -21.0% | -87.1% | +517.3% | +86.6% | +3.5% | -126.4% | – | – | |
| – | -19.2% | -101.7% | – | -32.7% | +28.6% | -73.4% | +188.6% | +78.9% | -3.3% | -94.7% | -919.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.